Case Study: Integrated Patient Support for Psoriatic Disease

Background

The Challenge

People living with psoriatic disease (psoriasis and psoriatic arthritis) often face challenges starting and continuing treatment that can affect their health and quality of life.
Patients’ experiences, beliefs, and psychosocial factors play a key role in motivation and ongoing treatment adherence.
Understanding and addressing these factors can help support patients to stay engaged with their treatment and achieve better outcomes.

Our Behaviour Change Approach

Patient research explored the psychosocial challenges people face during treatment, including factors that can affect motivation and lead to treatment discontinuation.
Research with healthcare professionals helped build understanding of which patients may benefit most from treatment, to support appropriate and timely care.
Insights from clinicians also informed how patient needs, circumstances, and treatment suitability are considered in decision‑making.

A programme designed to make the treatment experience easier and more supportive for people living with psoriatic disease.
Clear, easy‑to‑use information and touchpoints that help patients understand what to expect and feel supported throughout their treatment journey.
Regular, timely communications (e.g., nurse-led calls, emails) to provide reassurance, answer questions, and support ongoing engagement with treatment.
Opportunities for patients to share their experiences and report how treatment is affecting their symptoms and quality of life, helping ensure care remains responsive to their needs.

83% persistence at 12 months across enrolled patients vs non-programme¹ persistence of 64% (approximately 30% relative lift in persistence)
HCPs reported high satisfaction with supporting services and ease of patient enrolment and management